All articles
settings icon Categories
What Is Pharmaceutical Parallel Import? A Guide for Procurement and Supply Chain Teams
Parallel Trade

What Is Pharmaceutical Parallel Import? A Guide for Procurement and Supply Chain Teams

Introduction Pharmaceutical pricing varies significantly between national markets, even within highly integrated regulatory regions such as the European Union. A medicine reimbursed at a lower price in Spain or Greece may cost substantially more in Germany, Sweden, or Denmark due to differences in national pricing policies, reimbursement negotiations, and procurement
Read Article right arrow
How to Identify Local Distributors for Pharmaceutical Manufacturers by Market
Pharmaceutical Supply Chain

How to Identify Local Distributors for Pharmaceutical Manufacturers by Market

PharmaFootpath bridges the gap in pharmaceutical supply chains by identifying the specific distributors for manufacturers in different markets. A must-read for sourcing and BD teams looking for verified market access
Read Article right arrow
A Leaner Alternative to IQVIA for Pharma Trade Intelligence
Pharmaceutical procurement

A Leaner Alternative to IQVIA for Pharma Trade Intelligence

IQVIA’s enterprise data too complex or costly for your current needs? PharmaFootpath provides focused EU trade and licensing insights at accessible pricing - purpose-built for MA holders and WDA licensees.
Read Article right arrow
How to Identify Parallel Trade Licenses in the EU: A Guide for MA Holders
Parallel Trade

How to Identify Parallel Trade Licenses in the EU: A Guide for MA Holders

MA holders struggle to track where their products are being parallel traded. This guide shows how to find EU parallel trade licenses and what they reveal.
Read Article right arrow
EMA product updates - 17th March

EMA product updates - 17th March

We've decided to move this post to Mondays instead of Fridays. But will continue to capture important changes. The latest updates on EMA product registrations in the last week include With the launch of Zefylti, there are now 8 different biosimilars for Neupogen in the markets, a competitive
Read Article right arrow